Koninklijke Philips N.V. (PHG) Research
Koninklijke Philips N.V. (PHG) functions as a prominent health technology enterprise, with its operations spanning across North America and numerous international markets. The company's diverse activities are organized into three primary business divisions: Diagnosis & Treatment, Connected Care, and Personal Health. Within its Diagnosis & Treatment segment, Philips delivers advanced diagnostic imaging solutions, which include magnetic resonance imaging (MRI), computed tomography (CT) systems, X-ray apparatus, and spectral CT technology based on detector platforms. This division also provides molecular and hybrid imaging capabilities crucial for nuclear medicine. Furthermore, it offers integrated systems for interventional procedures, along with ultrasound (echography) solutions specifically designed for diagnosis, treatment planning, and guidance in fields such as cardiology, general imaging, obstetrics/gynecology, and point-of-care applications. Complementing these are proprietary software tools for diagnostic and interventional support, alongside comprehensive enterprise diagnostic informatics products and associated services. The Connected Care division focuses on providing solutions for acute patient management, emergency care services, and specialized offerings for sleep and respiratory conditions. This also encompasses electronic medical record (EMR) systems and broader care management platforms. Meanwhile, the Personal Health segment caters to consumer well-being with products such as electric toothbrushes, replacement brush heads, interdental cleaning aids, and teeth whitening kits. It also manufactures infant feeding products and digital parental support tools, in addition to a range of male grooming and beauty products. Philips has forged significant strategic alliances, notably a collaboration with Ibex Medical Analytics Ltd. This partnership aims to jointly promote digital pathology and AI-driven solutions to hospitals, healthcare networks, and pathology laboratories worldwide. The company also maintains a key partnership agreement with NICO.LAB. Established in 1891, the company was initially known as Koninklijke Philips Electronics N.V. before officially rebranding as Koninklijke Philips N.V. in May 2013. Its corporate headquarters are located in Amsterdam, the Netherlands.
Market snapshot
- Symbol
- PHG
- Price
- $26.78
- Day change
- +2.06%
- Market cap
- $22.8B
- P/E ratio
- 23.04x
- 52-week range
- 22.2-33.44
- Sector
- Healthcare
- Industry
- Medical - Devices
- Next earnings
- in 1 month
Recent news
- AI is boosting accuracy for clinicians, Philips North America CEO says
Artificial intelligence is helping improve accuracy in patient care and in some cases saving time and money, according to a survey sponsored by Philips , which provides diagnostic, imaging, and cloud technology to the healthcare industry, the CEO of its North American division said.
- Philips Reports Strong Order Intake Despite Uncertain Macro Environment
Koninklijke Philips N.V. (NYSE:PHG) shares were trading higher on Wednesday as the company reported strong order intake and comparable sales growth in its recent first quarter 2026 performance.
- Philips Sees Strong Sales Growth in Europe
Royal Philips posted a drop in first-quarter sales on a nominal basis, even as the health-tech group saw particularly strong growth in Western Europe.
Peer companies
Open Koninklijke Philips N.V. (PHG) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.